Results 231 to 240 of about 47,897 (254)
Finerenone ameliorates diabetic kidney disease exacerbated by deletion of natriuretic peptide/guanylyl cyclase-A signaling and dietary high-protein load. [PDF]
Inoue Y +15 more
europepmc +1 more source
The Inflammatory Cell Death in Diabetic Kidney Disease: Integrating Multifactorial Mechanisms into Novel Therapeutics. [PDF]
Fang B +5 more
europepmc +1 more source
Serum Factors in Primary Podocytopathies. [PDF]
Filippone EJ, Farber JL.
europepmc +1 more source
Innovative Technologies for Kidney Research: Three-Dimensional Imaging and Quantification. [PDF]
McLarnon SR, N'Guetta PY, O'Brien LL.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
METTL3-mediated m6A modification of TIMP2 mRNA promotes podocyte injury in diabetic nephropathy
Molecular Therapy, 2022Ling Jiang, Li Gao, Xiao-ming Meng
exaly
Mechanisms of podocyte injury and implications for diabetic nephropathy
Clinical Science, 2022Federica Barutta +2 more
exaly
Podocyte–actin dynamics in health and disease
Nature Reviews Nephrology, 2016Luca Perico, Sara Conti, Ariela Benigni
exaly

